Bell Therapeutics is a biotechnology startup that recently secured a Seed Round investment on 20 September 2023. The funding round was backed by HG Ventures, FuturePlay, and KOSME. This investment is a testament to the promising potential of Bell Therapeutics in the biotechnology industry. As the company continues to advance its innovative solutions, the support from prominent investors further validates its trajectory and sets the stage for impactful growth.
General Information
BounceWatch is an independent company data service, not affiliated with Bell Therapeutics. To contact Bell Therapeutics, visit belltherapeutics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Bell Therapeutics compare?
A PDF of Bell Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Bell Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Biotechnology
About Bell Therapeutics
Funding Rounds & Investors (1)
View AllWe're actively collecting intelligence on Bell Therapeutics.
Source: BounceWatch company record for Bell Therapeutics, https://bouncewatch.com/company/bell-therapeutics, updated 1 August 2024. When citing, please name BounceWatch and link this page.